Drug Shortage Report for CAVERJECT STERILE POWDER
Report ID | 154018 |
Drug Identification Number | 02215756 |
Brand name | CAVERJECT STERILE POWDER |
Common or Proper name | CAVERJECT |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | ALPROSTADIL |
Strength(s) | 20MCG |
Dosage form(s) | POWDER FOR SOLUTION LIQUID KIT |
Route of administration | INTRACAVERNOSAL INTRACAVERNOSAL |
Packaging size | 5 X 20MCG |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-03-25 |
Actual start date | 2022-03-02 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-05-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v17 | 2023-05-03 | French | Compare |
v16 | 2023-05-03 | English | Compare |
v15 | 2023-02-16 | French | Compare |
v14 | 2023-02-16 | English | Compare |
v13 | 2022-10-21 | French | Compare |
v12 | 2022-10-21 | English | Compare |
v11 | 2022-06-23 | French | Compare |
v10 | 2022-06-23 | English | Compare |
v9 | 2022-06-06 | French | Compare |
v8 | 2022-06-06 | English | Compare |
v7 | 2022-03-14 | French | Compare |
v6 | 2022-03-14 | English | Compare |
v5 | 2022-03-03 | English | Compare |
v4 | 2022-03-02 | French | Compare |
v3 | 2022-03-02 | English | Compare |
v2 | 2022-02-01 | French | Compare |
v1 | 2022-02-01 | English | Compare |
Showing 1 to 17 of 17